Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Ravi Parikh"'
Autor:
Seigo Yoneyama, Ayumi Fukui, Yoichi Sakurada, Nobuhiro Terao, Taiyo Shijo, Natsuki Kusada, Atsushi Sugiyama, Mio Matsubara, Yoshiko Fukuda, Wataru Kikushima, Ravi Parikh, Fumihiko Mabuchi, Chie Sotozono, Kenji Kashiwagi
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract To investigate the differences in clinical and genetic characteristics between males and females with central serous chorioretinopathy (CSC). Consecutive 302 patients (mean age; 56.3 ± 11.7, male/female: 249/53) with CSC were evaluated on t
Externí odkaz:
https://doaj.org/article/bfb0dde9f3ca4978a018dc892df7314c
Autor:
Tedi Begaj, Amy Yuan, Ines Lains, Ashley Li, Samuel Han, Gayatri Susarla, Ravi Parikh, Lucia Sobrin
Publikováno v:
Biomedicines, Vol 11, Iss 5, p 1268 (2023)
Choroidal caverns (CCs) have been described in association with age-related macular degeneration and pachychoroid disease. However, it is unknown if caverns are found in patients with chronic non-infectious uveitis (NIU). Herein, we evaluated patient
Externí odkaz:
https://doaj.org/article/39f1fe17038e4325a13f82726930f5e1
Autor:
Sumit Randhir Singh, Ravi Parikh, Yoichi Sakurada, Bhushan Uplanchiwar, Ahmad Mansour, Abhilash Goud, Yasha S Modi, Jay Chhablani
Publikováno v:
Taiwan Journal of Ophthalmology, Vol 10, Iss 4, Pp 289-293 (2020)
PURPOSE: The purpose of this study was to compare intravitreal ziv-aflibercept (IVZ) monotherapy to intravitreal bevacizumab (IVB) monotherapy in patients with exudative age-related macular degeneration (eAMD). MATERIALS AND METHODS: Patients with tr
Externí odkaz:
https://doaj.org/article/89faf88e886b45a982a059191cec13bf
Autor:
Wataru Kikushima, Atsushi Sugiyama, Seigo Yoneyama, Mio Matsubara, Yoshiko Fukuda, Ravi Parikh, Yoichi Sakurada
Publikováno v:
PLoS ONE, Vol 15, Iss 3, p e0230505 (2020)
[This corrects the article DOI: 10.1371/journal.pone.0229231.].
Externí odkaz:
https://doaj.org/article/94c63f4c4b90470a814cbcdf70a40e44
Autor:
Kikushima Wataru, Atsushi Sugiyama, Seigo Yoneyama, Mio Matsubara, Yoshiko Fukuda, Ravi Parikh, Yoichi Sakurada
Publikováno v:
PLoS ONE, Vol 15, Iss 2, p e0229231 (2020)
We report 5-year visual and anatomical outcomes after combination therapy of photodynamic therapy (PDT) and intravitreal injection of ranibizumab or aflibercept for polypoidal choroidal vasculopathy (PCV) and predictive factors for visual outcomes at
Externí odkaz:
https://doaj.org/article/ba7282aa40644cceb1dc1dad6521b0a2
Autor:
Mio Matsubara, Yoichi Sakurada, Atsushi Sugiyama, Yoshiko Fukuda, Ravi Parikh, Kenji Kashiwagi
Publikováno v:
PLoS ONE, Vol 15, Iss 8, p e0237330 (2020)
We investigated whether response to photodynamic therapy (PDT) with intravitreal aflibercept injection (IAI) for polypoidal choroidal vasculopathy (PCV) differs depending on fellow eye condition. A retrospective review was conducted for consecutive 6
Externí odkaz:
https://doaj.org/article/c709306a25b04bc1b89a46d26fdd2890
Autor:
Sachi A. Patil, Victor J. Sanchez, Georgia Bank, Archana A. Nair, Saagar Pandit, Joel S. Schuman, Vaidehi Dedania, Ravi Parikh, Nitish Mehta, Kathryn Colby, Yasha S. Modi
Publikováno v:
Journal of VitreoRetinal Diseases. 7:125-131
Purpose: To study patient follow-up after they engage in a teleretinal screening program and to understand potential barriers to care. Methods: This was a retrospective analysis and a prospective study of telephone-based patient interviews of outpati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7757fdcb928c1baebca2ebf6dc828f74
https://doi.org/10.1177/24741264221147103
https://doi.org/10.1177/24741264221147103
Autor:
Andrea K. Miyahira, Jessica E. Hawley, Remi Adelaiye‐Ogala, Jeremie Calais, Lucia Nappi, Ravi Parikh, Tyler M. Seibert, Elizabeth V. Wasmuth, Xiao X. Wei, Kenneth J. Pienta, Howard R. Soule
Publikováno v:
The Prostate. 83:207-226
The 2022 Coffey-Holden Prostate Cancer Academy (CHPCA) Meeting, "Exploring New Frontiers in Prostate Cancer Research," was held from June 23 to 26, 2022, at the University of California, Los Angeles, Luskin Conference Center, in Los Angeles, CA.The C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45435c04a74dd6986f009b343fa8868e
https://doi.org/10.1002/pros.24461
https://doi.org/10.1002/pros.24461
Publikováno v:
JAMA Ophthalmol
IMPORTANCE: The study team investigated costs associated with the ranibizumab port delivery system (PDS) for neovascular age-related macular (nAMD), an alternative to conventional intravitreal anti–vascular endothelial growth factor (VEGF) injectio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3a198a51aad75c8f5c282314b68beb3
https://pubmed.ncbi.nlm.nih.gov/35708666
https://pubmed.ncbi.nlm.nih.gov/35708666
Autor:
Joan W. Miller, Mary E. Aronow, Tedi Begaj, John B Miller, Lucy H. Young, Rachel M. Huckfeldt, Jan A. Kylstra, Demetrios G. Vavvas, Deeba Husain, Dean Eliott, David M. Wu, Shizuo Mukai, Leo A. Kim, Evan Chen, Sachi Patil, Lucia Sobrin, Karen M Wai, Ravi Parikh, Evangelos S. Gragoudas, Nimesh A. Patel
Publikováno v:
Seminars in Ophthalmology. 37:902-908
Purpose: To examine the effect of medication sample use (ranibizumab or aflibercept) on future anti-vascular endothelial growth factor (VEGF) agent selection in neovascular age-related macular degeneration (nvAMD). Design: Retrospective cohort study.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23a0ed3add15c9d7925479308073a5c4
https://doi.org/10.1080/08820538.2022.2107398
https://doi.org/10.1080/08820538.2022.2107398